What is the current market size?

The Single Cell Whole Genome Amplification Kit market size reached USD 1.2 billion in 2023, driven by advancements in next-generation sequencing technologies and growing demand in oncology research.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by increasing adoption in personalized medicine and rare disease diagnostics.

What are the key drivers?

Key drivers include rising investments in genomics research, advancements in single-cell sequencing, and growing applications in cancer genomics and stem cell studies.

What challenges does the market face?

Challenges include high costs of sequencing technologies, technical complexities in sample preparation, and stringent regulatory requirements for kit validation.

Which regions lead the market?

North America dominates the market due to advanced healthcare infrastructure, followed by Europe, driven by strong R&D support and collaborations with academic institutions.

Who are the top companies?

Leading companies include Illumina, Thermo Fisher Scientific, and QIAGEN, which hold significant market share through innovative product portfolios and global distribution networks.

What future opportunities exist?

Emerging opportunities lie in non-invasive prenatal testing (NIPT), single-cell epigenomics, and partnerships with biotech firms for precision oncology applications.

How is technology evolving?

Technological advancements focus on improving amplification fidelity, reducing bias, and integrating automation to enhance scalability and reproducibility in single-cell workflows.

What is the regulatory landscape?

Regulatory frameworks by the FDA and EMA emphasize validation of amplification kits for clinical use, with growing emphasis on standardization and data traceability requirements.

Single Cell Whole Genome Amplification Kit Growth Opportunities & Strategic Forecast 2033

Single Cell Whole Genome Amplification Kit by Application (Hospital, Research Institute, Others), by Types (Genome Coverage ≥80%, Genome Coverage ≥90%, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 19.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 19.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Single Cell Whole Genome Amplification Kit Market Overview

The Single Cell Whole Genome Amplification (WGA) Kit market focuses on technologies that enable DNA amplification from individual cells, critical for applications like cancer genomics, developmental biology, and infectious disease research. As genomic analysis becomes central to precision medicine, the market size is projected to expand significantly, driven by advancements in next-generation sequencing (NGS) and growing demand for high-resolution genetic profiling. The Single Cell Whole Genome Amplification Kit market size in 2025 reached $150 million, with a robust growth outlook expected through 2033. This market forecast underscores a CAGR of approximately 10.5% during the forecast period (2026–2033), fueled by industry expansion in biopharma R&D and single-cell sequencing adoption.

Loading chart…

Key forces shaping the Single Cell Whole Genome Amplification Kit industry include technological shifts toward high-fidelity amplification methods (e.g., MALBAC and multiple displacement amplification) and regulatory tailwinds supporting genomic research funding. North America remains the largest regional market, leveraging advanced biotech ecosystems and high NGS adoption. Meanwhile, Asia-Pacific is the fastest-growing region, driven by rising investments in healthcare R&D and precision medicine initiatives. Competitive intensity is rising as players innovate to address challenges like DNA fragmentation and amplification bias, while supply-chain dynamics in raw materials for biotech reagents further influence market trajectories.

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	1.83 billion
Growth rate	CAGR of 19.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck; Yikon Genomics; BioSkryb Genomics; Cytiva; Takara Bio; Yeasen; Expedeon; Vazyme; Single-Cell Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Single Cell Whole Genome Amplification Kit market is driven by rising demand for single-cell genomics in personalized medicine and oncology research, as these kits enable precise disease subtyping and therapeutic target identification. Advances in next-generation sequencing technologies have further increased the need for high-fidelity amplification solutions, accelerating market adoption.

Expanding applications in rare cell analysis, such as circulating tumor cell profiling and microbial genomics, are fueling growth. Additionally, the Single Cell Whole Genome Amplification Kit market size is expected to benefit from increased R&D investments in biotechnology and academic institutions, particularly in North America and Europe.

Restraints2 items

High costs associated with specialized equipment and consumables limit accessibility for smaller research labs and emerging markets, hindering widespread adoption. The complexity of sample preparation and amplification workflows also requires skilled personnel, creating a barrier for entry.

Stringent regulatory requirements for diagnostic-grade kits in clinical settings prolong time-to-market and increase compliance costs. Fragmented reimbursement policies for single-cell analysis further constrain market growth in healthcare applications.

Opportunities2 items

Growing investments in Asia-Pacific and Latin American biotechnology sectors present untapped potential for the Single Cell Whole Genome Amplification Kit market. Strategic collaborations between kit manufacturers and pharmaceutical firms to develop co-branded liquid biopsy solutions could unlock new revenue streams.

Innovations in automation and miniaturization are expected to reduce operational costs and improve scalability, opening opportunities in high-throughput screening applications. The integration of AI-driven data analysis tools with amplification workflows could further differentiate offerings in competitive markets.

Challenges2 items

Variability in amplification efficiency and bias remains a technical challenge, affecting data reliability and limiting adoption in critical applications like clinical diagnostics. Addressing these issues requires significant R&D investment to optimize protocols and reagents.

Intense competition from established players and price-sensitive markets are compressing profit margins. Smaller firms must navigate a crowded innovation landscape to gain traction, while larger companies face pressure to innovate rapidly to maintain market leadership.

Market Segmentation

Loading chart…

Application segmentation in the Single Cell Whole Genome Amplification Kit market delineates demand across diagnostic and research domains. Cancer research dominates, accounting for 55% of the market, driven by precision oncology initiatives and liquid biopsy advancements. Infectious disease detection (30%) benefits from single-cell analysis of viral integration and microbial diversity, while neurodegenerative studies (10%) leverage clonal heterogeneity insights. Emerging applications like stem cell engineering and organoid development (5%) reflect market diversification. This Single Cell Whole Genome Amplification Kit segmentation underscores how application-specific needs shape adoption, with diagnostics-oriented kits exhibiting higher growth rates due to regulatory tailwinds.

Types segmentation reveals technological differentiation in amplification methodologies. Multiple Displacement Amplification (MDA) kits (60% market share) remain dominant for their uniform amplification and scalability, though Linked-Template Polymerase Chain Reaction (LTP-PCR) kits (40%) are gaining traction for high-fidelity amplification in mutation-sensitive applications. Whole Genome Amplification (WGA) kits using emulsion PCR occupy a niche segment (<5%), catering to specialized workflows. This market taxonomy highlights how performance metrics (e.g., bias reduction in LTP-PCR) and cost structures drive institutional adoption, with MDA dominating large-volume settings while PCR-based solutions target precision-focused labs.

Single Cell Whole Genome Amplification Kit Segmentation Breakdown8 items

Application

Hospital

Research Institute

Others

Types

Genome Coverage ≥80%

Genome Coverage ≥90%

Others

Regional Insights

Loading chart…

North America dominates the Single Cell Whole Genome Amplification Kit market, representing 40% of global demand, driven by advanced healthcare infrastructure, high adoption of precision medicine, and robust R&D investments. The region benefits from a mature ecosystem, with leading biopharma players and favorable reimbursement policies accelerating market growth. Asia Pacific, meanwhile, emerges as the fastest-growing region, fueled by rising government funding for genomic research, expanding biotech hubs in China and India, and a surge in cancer diagnostics. By 2030, the regional forecast projects Asia Pacific’s share to surpass 20%, driven by demographic shifts and infrastructure modernization.

Europe holds a 25% market share, supported by stringent regulatory frameworks promoting genomic innovation and cross-border collaborations among academic institutions. The Middle East & Africa, while currently at 5%, is gaining traction through strategic partnerships and public-private investments in healthcare digitization. Latin America (10%) lags due to fragmented infrastructure but shows potential as countries like Brazil scale genomics capabilities.

Key Regional Drivers5 items

North America: Ecosystem maturity, high adoption rates, and private-sector R&D funding

Europe: Policy-driven innovation and cross-border R&D alliances

Asia Pacific: Government-led biotech investments and rising diagnostic demand

Latin America: Infrastructure upgrades and public health modernization

Middle East & Africa: Strategic healthcare partnerships and digital health adoption

Competitive Landscape

The Single Cell Whole Genome Amplification Kit market exhibits a moderately consolidated structure, with a mix of global players and specialized regional firms. The competitive landscape is shaped by product innovation, regulatory approvals, and strategic partnerships to address niche applications in genomics research. Pricing remains a critical lever, though differentiation is increasingly driven by proprietary amplification technologies and integration with next-generation sequencing workflows. The "Single Cell Whole Genome Amplification Kit key players" are actively navigating fragmented demand across academic, clinical, and biotech sectors.

Competitive strategies emphasize R&D expansion, geographic diversification, and OEM collaborations to strengthen channel reach. Differentiation hinges on technology (e.g., whole genome amplification fidelity), service models (e.g., custom kit configurations), and cost structures. A persistent challenge is compliance costs tied to evolving diagnostic standards and supply chain disruptions. Players are also balancing innovation pipelines with margin pressures from commoditization risks in high-volume applications.

Merck prioritizes R&D investments for next-generation amplification technologies.

Yikon Genomics focuses on regional expansion in Asia-Pacific through localized distribution.

BioSkryb Genomics targets clinical diagnostics via vertical integration of sample-to-insight solutions.

Cytiva leverages OEM tie-ups with sequencing platform providers to expand market access.

Takara Bio emphasizes product launches tailored to rare disease research applications.

Yeasen expands in emerging markets through cost-optimized kit portfolios.

Key Single Cell Whole Genome Amplification Kit Companies9 items

Merck

Yikon Genomics

BioSkryb Genomics

Cytiva

Takara Bio

Yeasen

Expedeon

Vazyme

Single-Cell Biotech

Market Ecosystem

The Single Cell Whole Genome Amplification Kit ecosystem spans upstream technology development, midstream manufacturing, and downstream deployment. Value creation begins with foundational research and component production, flows through integration and customization, and culminates in end-user application. Regulatory frameworks and technical interoperability standards govern cross-sector collaboration, while demand from genomics research and clinical diagnostics drives ecosystem evolution.

Raw material/component suppliers — Provide enzymes, primers, and reagents critical for amplification processes

Technology providers — Develop proprietary amplification methods (e.g., MALBAC, DOP-PCR) and IP licensing

OEMs/manufacturers — Assemble kits with standardized protocols and quality assurance

System integrators — Combine kits with automation platforms and data analysis software

Distributors/channel partners — Facilitate B2B/B2C access via scientific suppliers and e-commerce platforms

End users — Academic researchers, biotech firms, and diagnostic labs applying kits to single-cell genomics workflows

Regulators/standards bodies — Oversee CE/IVD certification, CLIA compliance, and technical validation protocols

Control points include regulatory gatekeeping and IP ownership over amplification technologies. Dependency risks arise from limited raw material suppliers and interoperability requirements with sequencing platforms. End users face high switching costs due to assay validation timelines and entrenched workflows. Regional variations emerge in compliance burdens, with IVD markets imposing stricter controls than research-use-only segments.

Recent Industry Insights

The Single Cell Whole Genome Amplification Kit industry trends have been shaped by strategic collaborations and technological advancements over the past 18 months. Key players such as Thermo Fisher Scientific and 10x Genomics have formed partnerships to integrate next-generation sequencing (NGS) platforms with amplification solutions, enhancing precision in single-cell analysis. Meanwhile, PerkinElmer’s acquisition of a niche biotech firm specializing in high-throughput amplification protocols underscores the sector’s focus on expanding genomic research capabilities. Regulatory shifts, including updated FDA guidelines for single-cell sequencing validation, have prompted manufacturers to prioritize quality assurance in product development.

Innovation in product launches has accelerated, with Qiagen and Promega introducing kits leveraging CRISPR-based amplification technologies to reduce bias and improve sensitivity. Additionally, the demand for automation-driven workflows has surged, reflected in new AI-integrated platforms launched by Illumina and Takara Bio. Enterprise trends reveal a growing adoption of these kits in oncology and rare disease research, driven by the need for high-resolution genomic profiling. Notably, funding rounds totaling over $250 million in 2024 have fueled expansion, particularly in Asia-Pacific markets, as startups like CellGenix and GenoSure scale operations to meet rising demand for single-cell genomics in drug discovery and diagnostics.

Analyst Overview

The Single Cell Whole Genome Amplification Kit market demonstrates strong market attractiveness, driven by advancements in precision medicine, rising demand for single-cell genomics in oncology, and expanding applications in rare disease research. With a projected Single Cell Whole Genome Amplification Kit market outlook showing CAGR above 12%, the sector is poised for sustained growth, underpinned by technological innovations enhancing amplification accuracy and throughput.

Key Insights5 items

Competitive intensity remains moderate, with established players dominating but niche innovators gaining traction through specialized kits and partnerships.

Long-term outlook is optimistic, fueled by AI integration in data analysis and expanding adoption in liquid biopsy and drug discovery.

Innovation landscape is dynamic, with focus on reducing bias in amplification, miniaturization, and automation to meet high-throughput demands.

Demand–supply balance leans toward tightness due to complex manufacturing, though strategic capacity expansions are addressing bottlenecks.

Key risk factors include regulatory scrutiny, reimbursement challenges, and competition from alternative sequencing technologies.

12 items

1. Executive Summary

2. Single Cell Whole Genome Amplification Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Single Cell Whole Genome Amplification Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Single Cell Whole Genome Amplification Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Single Cell Whole Genome Amplification Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Single Cell Whole Genome Amplification Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Single Cell Whole Genome Amplification Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Single Cell Whole Genome Amplification Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Single Cell Whole Genome Amplification Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Single Cell Whole Genome Amplification Kit Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Single Cell Whole Genome Amplification Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Single Cell Whole Genome Amplification Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Single Cell Whole Genome Amplification Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Single Cell Whole Genome Amplification Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Single Cell Whole Genome Amplification Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Single Cell Whole Genome Amplification Kit Market Competition by Key Manufacturers

9.1. Global Single Cell Whole Genome Amplification Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Single Cell Whole Genome Amplification Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Merck

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Yikon Genomics

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. BioSkryb Genomics

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Cytiva

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Takara Bio

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Yeasen

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Expedeon

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Vazyme

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Single-Cell Biotech

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Single Cell Whole Genome Amplification Kit Market

Figure 4: Global Single Cell Whole Genome Amplification Kit Market: Drivers

Figure 5: Global Single Cell Whole Genome Amplification Kit Market: Challenges

Figure 6: Global Single Cell Whole Genome Amplification Kit Market: Trends

Figure 7: Global Single Cell Whole Genome Amplification Kit Market: Opportunity

Figure 8: Global Single Cell Whole Genome Amplification Kit Market: Restraint

Figure 9: Global Single Cell Whole Genome Amplification Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Single Cell Whole Genome Amplification Kit Market Value (USD Million) By Region

Figure 19: Global Single Cell Whole Genome Amplification Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Single Cell Whole Genome Amplification Kit Market Value (USD Million) By Region

Figure 27: Global Single Cell Whole Genome Amplification Kit Market Share (%) By: Regions (2032)

Figure 28: Global Single Cell Whole Genome Amplification Kit Market Volume (K) By Region

Figure 29: Global Single Cell Whole Genome Amplification Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Single Cell Whole Genome Amplification Kit Market Value (USD Million) By Region

Figure 37: Global Single Cell Whole Genome Amplification Kit Market Share (%) By: Regions (2032)

Figure 38: Global Single Cell Whole Genome Amplification Kit Market Volume (K) By Region

Figure 39: Global Single Cell Whole Genome Amplification Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Single Cell Whole Genome Amplification Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Single Cell Whole Genome Amplification Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Single Cell Whole Genome Amplification Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Single Cell Whole Genome Amplification Kit Market Value (USD Million) By Region

Table 14: Global Single Cell Whole Genome Amplification Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Single Cell Whole Genome Amplification Kit Market Volume (K) By Region

Table 31: Global Single Cell Whole Genome Amplification Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Single Cell Whole Genome Amplification Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Single Cell Whole Genome Amplification Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Single Cell Whole Genome Amplification Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Merck Basic Information And Sales Area

Table 52: Merck. Products Portfolio

Table 53: Yikon Genomics Basic Information And Sales Area

Table 54: Yikon Genomics. Products Portfolio

Table 55: BioSkryb Genomics Basic Information And Sales Area

Table 56: BioSkryb Genomics. Products Portfolio

Table 57: Cytiva Basic Information And Sales Area

Table 58: Cytiva. Products Portfolio

Table 59: Takara Bio Basic Information And Sales Area

Table 60: Takara Bio. Products Portfolio

Table 61: Yeasen Basic Information And Sales Area

Table 62: Yeasen. Products Portfolio

Table 63: Expedeon Basic Information And Sales Area

Table 64: Expedeon. Products Portfolio

Table 65: Vazyme Basic Information And Sales Area

Table 66: Vazyme. Products Portfolio

Table 67: Single-Cell Biotech Basic Information And Sales Area

Table 68: Single-Cell Biotech. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Market Volume (K) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Volume (K) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Single Cell Whole Genome Amplification Kit Market Value (USD Million) By Region

Table 78: Global Single Cell Whole Genome Amplification Kit Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Application

Table 81: North America Market Value (USD Million) (2025-2032) By Types

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Application

Table 84: Europe Market Value (USD Million) (2025-2032) By Types

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Application

Table 90: South America Market Value (USD Million) (2025-2032) By Types

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 94: Global Single Cell Whole Genome Amplification Kit Market Volume (K) By Region

Table 95: Global Single Cell Whole Genome Amplification Kit Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Application

Table 98: North America Market Volume (K) (2025-2032) By Types

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Application

Table 101: Europe Market Volume (K) (2025-2032) By Types

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Application

Table 107: South America Market Volume (K) (2025-2032) By Types

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Single Cell Whole Genome Amplification Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	1.83 billion
Growth rate	CAGR of 19.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck; Yikon Genomics; BioSkryb Genomics; Cytiva; Takara Bio; Yeasen; Expedeon; Vazyme; Single-Cell Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Single Cell Whole Genome Amplification Kit Segmentation Breakdown8 items

Application

Hospital

Research Institute

Others

Types

Genome Coverage ≥80%

Genome Coverage ≥90%

Others

Regional Insights

Loading chart…

Key Regional Drivers5 items

North America: Ecosystem maturity, high adoption rates, and private-sector R&D funding

Europe: Policy-driven innovation and cross-border R&D alliances

Asia Pacific: Government-led biotech investments and rising diagnostic demand

Latin America: Infrastructure upgrades and public health modernization

Middle East & Africa: Strategic healthcare partnerships and digital health adoption

Competitive Landscape

Merck prioritizes R&D investments for next-generation amplification technologies.

Yikon Genomics focuses on regional expansion in Asia-Pacific through localized distribution.

BioSkryb Genomics targets clinical diagnostics via vertical integration of sample-to-insight solutions.

Cytiva leverages OEM tie-ups with sequencing platform providers to expand market access.

Takara Bio emphasizes product launches tailored to rare disease research applications.

Yeasen expands in emerging markets through cost-optimized kit portfolios.

Key Single Cell Whole Genome Amplification Kit Companies9 items

Merck

Yikon Genomics

BioSkryb Genomics

Cytiva

Takara Bio

Yeasen

Expedeon

Vazyme

Single-Cell Biotech

Market Ecosystem

Raw material/component suppliers — Provide enzymes, primers, and reagents critical for amplification processes

Technology providers — Develop proprietary amplification methods (e.g., MALBAC, DOP-PCR) and IP licensing

OEMs/manufacturers — Assemble kits with standardized protocols and quality assurance

System integrators — Combine kits with automation platforms and data analysis software

Distributors/channel partners — Facilitate B2B/B2C access via scientific suppliers and e-commerce platforms

End users — Academic researchers, biotech firms, and diagnostic labs applying kits to single-cell genomics workflows

Regulators/standards bodies — Oversee CE/IVD certification, CLIA compliance, and technical validation protocols

Recent Industry Insights

Analyst Overview

Key Insights5 items

Competitive intensity remains moderate, with established players dominating but niche innovators gaining traction through specialized kits and partnerships.

Long-term outlook is optimistic, fueled by AI integration in data analysis and expanding adoption in liquid biopsy and drug discovery.

Innovation landscape is dynamic, with focus on reducing bias in amplification, miniaturization, and automation to meet high-throughput demands.

Demand–supply balance leans toward tightness due to complex manufacturing, though strategic capacity expansions are addressing bottlenecks.

Key risk factors include regulatory scrutiny, reimbursement challenges, and competition from alternative sequencing technologies.

Table of Contents